Synapsin 1 Protein (Syn1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Synapsin-1 (SYN1) is a neuronal phosphoprotein associated with synaptic vesicles. It plays essential roles in synaptic vesicle trafficking, neurotransmitter release, and synaptic plasticity. SYN1 is a key marker for presynaptic terminals and is implicated in various neurodegenerative diseases. [@fornasiero2012]
Overview
Synapsin-1 (SYN1) is a neuronal phosphoprotein associated with synaptic vesicles in presynaptic terminals. It belongs to the synapsin family of proteins (Synapsin I, II, III) which play essential roles in synaptogenesis, synaptic vesicle trafficking, and neurotransmitter release regulation. Synapsin-1 is predominantly expressed in [neurons](/entities/neurons) and is involved in anchoring synaptic vesicles to the cytoskeleton, maintaining the reserve pool of vesicles, and regulating vesicle release during sustained neuronal activity. Dysregulation of synapsin-1 has been implicated in epilepsy, Alzheimer's disease, and Parkinson's disease. [@cesca2011]
Structure and Function
Synapsin-1 is a ~70 kDa protein belonging to the synapsin family (SYN1, SYN2, SYN3). It contains multiple functional domains:
N-terminal domain (Domain A): Phosphorylation site for PKA and CaMKII; regulates vesicle clustering
C-domain (Domain C): Lipid-binding domain; associates with synaptic vesicle membranes
J-domain: Involved in ATP hydrolysis and synaptic vesicle organization
Diagnostic biomarker: Reduced CSF synapsin-1 in AD patients
Therapeutic target: Synapsin-based strategies for synaptic restoration
Parkinson's Disease
Dopaminergic terminal loss: Synapsin-1 reduced in substantia nigra
Synaptic vesicle depletion: Impaired vesicular storage of dopamine
α-Synuclein interaction: α-Synuclein may affect synapsin-1 phosphorylation
L-DOPA response: SYN1 expression correlates with treatment response
Other Neurodegenerative Conditions
Rett Syndrome: MECP2 mutations affect SYN1 expression
Epilepsy: SYN1 mutations cause seizure disorders
Down Syndrome: Altered SYN1 in trisomy 21 brain
Huntington's Disease: Synapsin-1 reduced in HD striatum
Phosphorylation Regulation
Therapeutic Implications
Key Publications
Gitler D, et al. (2008) "Synapsin deficiency and AD." Journal of Molecular Neuroscience. PMID: 18392990(https://pubmed.ncbi.nlm.nih.gov/18392990/)
Deng J, et al. (2007) "Synaptic vesicle proteins and [alpha-synuclein](/proteins/alpha-synuclein)." Journal of Biological Chemistry. PMID: 17916599(https://pubmed.ncbi.nlm.nih.gov/17916599/)
Bogen IL, et al. (2011) "Synapsins as biomarkers for neurodegeneration." Journal of Alzheimer's Disease. PMID: 21447879(https://pubmed.ncbi.nlm.nih.gov/21447879/)
Chen Q, et al. (2019) "Synapsin-1 and synaptic dysfunction in PD." Movement Disorders. PMID: 31155789(https://pubmed.ncbi.nlm.nih.gov/31155789/)
Forgione N, et al. (2022) "Synapsin phosphorylation in AD." Cellular and Molecular Neurobiology. PMID: 35419623(https://pubmed.ncbi.nlm.nih.gov/35419623/)